Secretory organelles in ECL cells: effects of pharmacological blockade of the gastrin/CCK2 receptor versus its elimination by gene targeting

Inflammopharmacology. 2005;13(1-3):75-82. doi: 10.1163/156856005774423818.

Abstract

Histamine-producing ECL cells are numerous in the stomach. They express gastrin/CCK2 receptors and respond to gastrin by releasing histamine. Ultrastructurally, they display numerous and very characteristic secretory organelles: granules, secretory vesicles and microvesicles. This paper focuses on the impact of the gastrin/CCK2 receptor on the ultrastructure of the ECL cells. The effects of pharmacological blockade of the receptor are compared with the effects of receptor elimination following selective gene targeting. Long-term administration of powerful gastrin/CCK2 receptor antagonists was found to induce hypotrophy of rat stomach ECL cells with reduced number of granules, secretory vesicles and microvesicles. In gastrin/CCK2 receptor knockout mice ECL cells, i.e., histamine-storing cells with the characteristic ultrastructure of ECL cells, had disappeared from the oxyntic mucosa and been replaced by a novel population of endocrine-like cells. These cells harbored granules and microvesicles, but were devoid of histamine and secretory vesicles. We suggest that the gastrin/CCK2 receptor is important for the proper differentiation of the ECL cells and for maintaining their characteristic ultrastructure.

Publication types

  • Review

MeSH terms

  • Animals
  • Benzodiazepines / pharmacology
  • Benzodiazepinones / pharmacology
  • Enterochromaffin-like Cells / drug effects
  • Enterochromaffin-like Cells / metabolism*
  • Enterochromaffin-like Cells / ultrastructure
  • Mice
  • Mice, Knockout
  • Microscopy, Electron
  • Organelles / drug effects
  • Organelles / metabolism*
  • Organelles / ultrastructure
  • Phenylurea Compounds / pharmacology
  • Receptor, Cholecystokinin B / antagonists & inhibitors
  • Receptor, Cholecystokinin B / genetics
  • Receptor, Cholecystokinin B / physiology

Substances

  • Benzodiazepinones
  • Phenylurea Compounds
  • Receptor, Cholecystokinin B
  • Benzodiazepines
  • YM 022
  • YF 476